Pre-earnings options volume in Pacira is normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 27.4%, or $5.41, after results are released. Median move over the past eight quarters is 3.3%.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCRX:
- Pacira (PCRX) Q2 Earnings Cheat Sheet
- Pacira negative patent ruling most likely outcome, says JPMorgan
- CMS proposes new reimbursement for Exparel in outpatient surgical enviroments
- Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
- Intuit initiated, Charter downgraded: Wall Street’s top analyst calls